A postbiotic is a product containing non-living (e.g. pasteurised) microorganisms and/or their constituents with health-promoting effects.
Ingredients SANPROBI® PREMIUM Beauty – The Akkermansia Company™
| No. | Type | Species | Strain |
|---|---|---|---|
| 1. | Akkermansia | Muciniphila | Mucᵀ |
15 billion TFU of pasteurised Akkermansia muciniphila Mucᵀ bacteria in a capsule.
TFU – Total Fluorescent Unit (manufacturer’s methodology).
Additionally, the product contains:
| No. | Ingredient |
|---|---|
| 1. | Wild rose fruit extract (Rosa canina) DER 25:1 |
| 2. | Maritime pine bark extract (Pinus pinaster) – Pycnogenol® |
| 3. | Zinc picolinate |
| 4. | Bulking agent – microcrystalline cellulose |
| 5. | Haematococcus pluvialis algae powder |
| 6. | Anti-caking agent – magnesium salts of fatty acids |
| 7. | Capsule shell: hydroxypropyl methylcellulose |
- Wild rose fruit extract (Rosa canina) –a source of vitamin C, which contributes to normal collagen formation for the normal function of the skin, blood vessels, bones and cartilage. It also helps protect cells from oxidative stress and supports the normal function of the immune system.
- Zinc, which helps maintain healthy hair, nails and skin and supports the proper functioning of the body, including the protection of cells from oxidative stress and support of the immune system.
- Maritime pine bark extract (Pinus pinaster) – Pycnogenol®, a natural source of oligomeric proanthocyanidins (OPCs).
- Haematococcus pluvialis algae powder, a source of astaxanthin.
Each pack contains 40 capsules, and each capsule provides:
- 1.5 × 10¹⁰ TFU of the pasteurised bacterium Akkermansia muciniphila Mucᵀ
- 71.5 mg of wild rose fruit extract, providing 50 mg of vitamin C (62.5% NRV⁵)
- 50 mg of maritime pine bark extract – Pycnogenol®, providing 32.5 mg of oligomeric proanthocyanidins (OPCs)
- 37.5 mg of zinc picolinate, providing 7.5 mg of zinc (75% NRV⁵)
- 30 mg of Haematococcus pluvialis algae powder, providing 1.5 mg of astaxanthin
Dosage SANPROBI® PREMIUM Beauty – The Akkermansia Company™
Take 1 capsule twice a day, in the morning and in the evening, with a glass of water.
Do not exceed the recommended daily dose.
The product should not be used as a substitute for a balanced diet. Use of the product is not a substitute for a healthy lifestyle (moderate physical activity and a balanced diet).
More about SANPROBI® PREMIUM Beauty – The Akkermansia Company™
The product is intended for use by persons over 18 years of age, with the exception of pregnant and breastfeeding women.
The product does not contain any allergens, colourings, perfumes or preservatives.
The product does not contain lactose (detection limit 0.01g/100g), casein (detection limit 0.06 mg/kg), allergenic milk proteins (detection limit 0.05 mg/kg) and β-lactoglobulin (detection limit 0.0015 mg/kg).
It is GMO free. Suitable for vegans.
The product does not require refrigeration. Store at room temperature not exceeding 25°C and keep out of reach of small children.
Warnings
This product contains astaxanthin from Haematococcus pluvialis algae and should not be consumed if other food supplements containing astaxanthin are taken on the same day.
This product should not be consumed by pregnant or breastfeeding women, or by children under 18 years of age.
Additional information
Due to the legal requirements for food supplements, we are not allowed to make health claims about individual products in our content. However, we would like to remind you that the effect of probiotics depends on the strain of bacteria. This means that you can learn a lot about the properties of a product by knowing its composition. We follow evidence-based medicine, so we always encourage you to read scientific studies!
* Commission Regulation (EU) 2022/168 of 8 February 2022.
** Safety of pasteurised Akkermansia muciniphila as a novel food according to Regulation (EU) 2015/2283 (doi:10.2903/j.efsa.2021.6780).
*** Depommier C et al. Supplementaon with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096-1103. doi: 10.1038/s41591-019-0495-2.
